Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
2005 1
2012 1
2016 1
2017 5
2018 8
2019 6
2020 7
Text availability
Article attribute
Article type
Publication date

Search Results

28 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean yikuang lin (1 results)?
Nattokinase: A Promising Alternative in Prevention and Treatment of Cardiovascular Diseases.
Chen H, McGowan EM, Ren N, Lal S, Nassif N, Shad-Kaneez F, Qu X, Lin Y. Chen H, et al. Among authors: lin y. Biomark Insights. 2018 Jul 5;13:1177271918785130. doi: 10.1177/1177271918785130. eCollection 2018. Biomark Insights. 2018. PMID: 30013308 Free PMC article. Review.
PTEN/PTENP1: 'Regulating the regulator of RTK-dependent PI3K/Akt signalling', new targets for cancer therapy.
Haddadi N, Lin Y, Travis G, Simpson AM, Nassif NT, McGowan EM. Haddadi N, et al. Among authors: lin y. Mol Cancer. 2018 Feb 19;17(1):37. doi: 10.1186/s12943-018-0803-3. Mol Cancer. 2018. PMID: 29455665 Free PMC article. Review.
PD-1 disrupted CAR-T cells in the treatment of solid tumors: Promises and challenges.
McGowan E, Lin Q, Ma G, Yin H, Chen S, Lin Y. McGowan E, et al. Among authors: lin y. Biomed Pharmacother. 2020 Jan;121:109625. doi: 10.1016/j.biopha.2019.109625. Epub 2019 Nov 13. Biomed Pharmacother. 2020. PMID: 31733578 Free article. Review.
Novel anti-obesity effect of scutellarein and potential underlying mechanism of actions.
Lin Y, Ren N, Li S, Chen M, Pu P. Lin Y, et al. Biomed Pharmacother. 2019 Sep;117:109042. doi: 10.1016/j.biopha.2019.109042. Epub 2019 Jun 19. Biomed Pharmacother. 2019. PMID: 31228804 Free article.
Saikosaponin-d Suppresses COX2 Through p-STAT3/C/EBPβ Signaling Pathway in Liver Cancer: A Novel Mechanism of Action.
Ren M, McGowan E, Li Y, Zhu X, Lu X, Zhu Z, Lin Y, He S. Ren M, et al. Among authors: lin y. Front Pharmacol. 2019 May 29;10:623. doi: 10.3389/fphar.2019.00623. eCollection 2019. Front Pharmacol. 2019. PMID: 31191326 Free PMC article.
Comparative Efficacy and Tolerability of Neoadjuvant Immunotherapy Regimens for Patients with HER2-Positive Breast Cancer: A Network Meta-Analysis.
Wu D, Chen T, Jiang H, Duan C, Zhang X, Lin Y, Chen S, Wu F. Wu D, et al. Among authors: lin y. J Oncol. 2019 Mar 19;2019:3406972. doi: 10.1155/2019/3406972. eCollection 2019. J Oncol. 2019. PMID: 31015833 Free PMC article.
Reduced expression of CENP-E contributes to the development of hepatocellular carcinoma and is associated with adverse clinical features.
He P, Hu P, Yang C, He X, Shao M, Lin Y. He P, et al. Among authors: lin y. Biomed Pharmacother. 2020 Mar;123:109795. doi: 10.1016/j.biopha.2019.109795. Epub 2019 Dec 24. Biomed Pharmacother. 2020. PMID: 31881483 Free article.
Heart Rate Variability as a Biomarker for Predicting Stroke, Post-stroke Complications and Functionality.
Lees T, Shad-Kaneez F, Simpson AM, Nassif NT, Lin Y, Lal S. Lees T, et al. Among authors: lin y. Biomark Insights. 2018 Jul 18;13:1177271918786931. doi: 10.1177/1177271918786931. eCollection 2018. Biomark Insights. 2018. PMID: 30038486 Free PMC article. Review.
Good Guy or Bad Guy? The Duality of Wild-Type p53 in Hormone-Dependent Breast Cancer Origin, Treatment, and Recurrence.
McGowan EM, Lin Y, Hatoum D. McGowan EM, et al. Among authors: lin y. Cancers (Basel). 2018 May 31;10(6):172. doi: 10.3390/cancers10060172. Cancers (Basel). 2018. PMID: 29857525 Free PMC article. Review.
Recent advances in molecular biomarkers for diabetes mellitus: a systematic review.
Lees T, Nassif N, Simpson A, Shad-Kaneez F, Martiniello-Wilks R, Lin Y, Jones A, Qu X, Lal S. Lees T, et al. Among authors: lin y. Biomarkers. 2017 Nov;22(7):604-613. doi: 10.1080/1354750X.2017.1279216. Epub 2017 Jan 24. Biomarkers. 2017. PMID: 28074664 Review.
28 results
Jump to page